StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report published on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 1.2 % Brooklyn ImmunoTherapeutics stock opened at $3.26 on Tuesday. Brooklyn ImmunoTherapeutics has a twelve month low of $0.17 and a twelve month high […]

Related Keywords

Brooklyn Immunotherapeutics , Eterna Therapeutics Inc , Brooklyn Immunotherapeutics Inc , Advisors Group , Securities Exchange Commission , Get Rating , Street Advisors Group , Nyse Btx , Kbtx , Information , Initiated Coverage , Stocknews Com ,